Coronavirus Vaccine Candidate Shows Promise

With ever mounting deaths, scientists have been under pressure to develop a COVID-19 vaccine.

Moderna, Inc., reported that they have developed a COVID-19 vaccine that is safe. Phase I testing (45 subjects) appears to elicit the kind of immune response capable of preventing the disease. There were no no serious side-effects after the first trial. Source: NPR

Phase II can start right away, and the company hopes to start phase III in early July.